Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.

Leonard KapsC J AhlbrandR GadbanM NagelC LabenzP KlimpkeS HoltzS BoedeckerM MichelW M KremerM HilscherP R GalleD KrausJörn Markus Schattenberg Julia Weinmann-Menke

Published in: PloS one (2021)

Discontinuous ADVOS treatment was safe and effective in patients with ACLF outside intensive care and outperformed hemodialysis in reducing protein-bound metabolites.

Keyphrases

liver failure
hepatitis b virus
chronic kidney disease
ms ms
small molecule
binding protein